These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 23725674)

  • 1. Targeting protein-protein interactions as an anticancer strategy.
    Ivanov AA; Khuri FR; Fu H
    Trends Pharmacol Sci; 2013 Jul; 34(7):393-400. PubMed ID: 23725674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.
    Li Z; Ivanov AA; Su R; Gonzalez-Pecchi V; Qi Q; Liu S; Webber P; McMillan E; Rusnak L; Pham C; Chen X; Mo X; Revennaugh B; Zhou W; Marcus A; Harati S; Chen X; Johns MA; White MA; Moreno C; Cooper LA; Du Y; Khuri FR; Fu H
    Nat Commun; 2017 Feb; 8():14356. PubMed ID: 28205554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
    Harati S; Cooper LA; Moran JD; Giuste FO; Du Y; Ivanov AA; Johns MA; Khuri FR; Fu H; Moreno CS
    PLoS One; 2017; 12(1):e0170339. PubMed ID: 28118365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View.
    Dar KB; Bhat AH; Amin S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
    Curr Cancer Drug Targets; 2019; 19(6):430-448. PubMed ID: 30073927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The OncoPPi Portal: an integrative resource to explore and prioritize protein-protein interactions for cancer target discovery.
    Ivanov AA; Revennaugh B; Rusnak L; Gonzalez-Pecchi V; Mo X; Johns MA; Du Y; Cooper LAD; Moreno CS; Khuri FR; Fu H
    Bioinformatics; 2018 Apr; 34(7):1183-1191. PubMed ID: 29186335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Kinase Interaction Networks: A New Paradigm in PPI Based Design of Kinase Inhibitors.
    Jenardhanan P; Panneerselvam M; Mathur PP
    Curr Top Med Chem; 2019; 19(6):467-485. PubMed ID: 31184298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Architecture of Deregulated Protein Complexes in Cancer.
    Stefan E; Troppmair J; Bister K
    Adv Protein Chem Struct Biol; 2018; 111():101-132. PubMed ID: 29459029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
    Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
    Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design and development of covalent protein-protein interaction inhibitors for cancer treatment.
    Cheng SS; Yang GJ; Wang W; Leung CH; Ma DL
    J Hematol Oncol; 2020 Mar; 13(1):26. PubMed ID: 32228680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovering Innovative Drugs Targeting Both Cancer and Cardiovascular Disease by Shared Protein-Protein Interaction Network Analyses.
    Tiwari S; Dwivedi UN
    OMICS; 2019 Sep; 23(9):417-425. PubMed ID: 31329050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?
    Cierpicki T; Grembecka J
    Immunol Rev; 2015 Jan; 263(1):279-301. PubMed ID: 25510283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
    Jimenez CR; Verheul HM
    Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
    Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Framework for Prediction of Peptide Sequences That May Mediate Multiple Protein Interactions in Cancer-Associated Hub Proteins.
    Sarkar D; Patra P; Ghosh A; Saha S
    PLoS One; 2016; 11(5):e0155911. PubMed ID: 27218803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
    Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
    J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer.
    Matos B; Howl J; Jerónimo C; Fardilha M
    Pharmacol Res; 2020 Nov; 161():105145. PubMed ID: 32814172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-protein interactions: network analysis and applications in drug discovery.
    Bultinck J; Lievens S; Tavernier J
    Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.